TrialJournal of medical virology2022

Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19: A randomized clinical trial.

Mehdi Hassaniazad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.